SQZ Biotech to Present at Investor Conferences in First Quarter 2018

WATERTOWN, Mass., Feb. 5, 2018 /PRNewswire/ -- SQZ Biotech (SQZ), a preclinical stage biotechnology company developing cell therapies based on its proprietary CellSqueeze® technology, announced today that management will be presenting at three investor conferences in the first quarter of 2018.

BIO CEO and Investor Conference in New York, NY
February 12 - February 13, 2018
Presentation Time: February 12, 2018 at 10:30am

Cowen and Company Annual Healthcare Conference in Boston, MA
March 12 – March 14, 2018
Presentation Time: March 12, 2018 at 2:30pm

Oppenheimer Annual Healthcare Conference in New York, NY
March 20 – March 21, 2018
Presentation Time: March 21, 2018 at 8:35am

"We are thrilled to have the opportunity to present SQZ's vision of developing a new generation of cell-based therapies," remarked Armon Sharei, PhD, CEO at SQZ. "It is an honor to be selected as a private company and we look forward to discussing our potential to implement previously inaccessible therapies across multiple disease areas."

About SQZ Biotech
SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ's unique cell engineering capabilities are being used to develop a new generation of cell therapies to address a wide range of clinical challenges. For more information please visit www.sqzbiotech.com.

SQZ Contact:
Rebecca Cohen
Manager, Corporate Relations & Administration
[email protected] 
617-758-8672 ext. 728

SQZ Media Contact:
Justin Jackson
Burns McClellan 
212-213-0006, ext. 327 
[email protected]

SOURCE SQZ Biotechnologies